NASDAQ : CMLT
-$0.52 (-5.65%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-02-09 | The Vanguard Group - 23-1945930 | 25.95M | 5.31% |
| 2022-02-14 | XXVI Holdings Inc. | 47.25M | 9.69% |
| 2022-02-14 | Alphabet Holdings LLC | 47.25M | 9.69% |
| 2022-02-14 | GV 2019 GP, L.L.C. | 47.25M | 9.69% |
| 2022-02-14 | GV 2019 GP, L.P. | 47.25M | 9.69% |
| 2022-02-14 | Alphabet Inc. | 47.25M | 9.69% |
| 2022-02-14 | GV 2019, L.P. | 47.25M | 9.69% |
| 2022-02-11 | ARCH Venture Partners X Overage, L.P. | 36.34M | 7.50% |
| 2022-02-11 | ARCH Venture Fund X, L.P. | 36.34M | 7.50% |
| 2022-02-11 | ARCH Venture Fund X Overage, L.P. | 36.34M | 7.50% |
| 2022-02-11 | ARCH Venture Partners X, L.P. | 36.34M | 7.50% |
| 2022-02-11 | ARCH Venture Partners X, LLC | 36.34M | 7.50% |
| 2022-02-11 | Crandell | 36.34M | 7.50% |
| 2022-02-11 | Kristina Burow | 36.34M | 7.50% |
| 2022-02-11 | Robert Nelsen | 36.34M | 7.50% |
| 2022-02-11 | Gillis | 36.34M | 7.50% |
| 2021-12-27 | AH Equity Partners Bio III, L.L.C. (“AH Equity Bio III”) | 19.19M | 3.90% |
| 2021-12-27 | SB Management Limited | 43.98M | 9.00% |
| 2021-12-27 | SoftBank Group Corp. | 43.98M | 9.00% |
| 2021-12-27 | AH Bio Fund II, L.P. (“AH Bio II”) | 17.44M | 3.60% |
| 2021-12-27 | AH Equity Partners Bio II, L.L.C. (“AH Equity Bio II”) | 17.44M | 3.60% |
| 2021-12-27 | AH Bio Fund III, L.P. (“AH Bio III”) | 19.19M | 3.90% |
| 2021-12-27 | Andreessen Horowitz LSV Fund I, L.P. (“AH LSV I”) | 11.43M | 2.30% |
| 2021-12-27 | AH Equity Partners LSV I, L.L.C. (“AH Equity LSV I”) | 11.43M | 2.30% |
| 2021-12-27 | Andreessen Horowitz LSV Fund II, L.P. (“AH LSV II”) | 5M | 1.00% |
| 2021-12-27 | AH Equity Partners LSV II, L.L.C. (“AH Equity LSV II”) | 5M | 1.00% |
| 2021-12-27 | Marc Andreessen (“Andreessen”) | 53.06M | 10.90% |
| 2021-12-27 | Benjamin Horowitz (“Horowitz”) | 53.06M | 10.90% |
| 2021-12-10 | 2. | 10.0 | 0.20% |
| 2021-12-10 | 2. | 10.0 | 0.20% |
| 2021-12-10 | 2. | 10.0 | 0.20% |
| 2021-12-10 | 2. | 10.0 | 4.10% |
| 2021-12-10 | 2. | 10.0 | 4.10% |
| 2021-12-10 | 2. | 10.0 | 4.20% |
| 2021-12-10 | 2. | 10.0 | 4.10% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|